Arog Pharmaceuticals Announces Clinical Presentations on Crenolanib at the 23rd Congress of the European Hematology Association
06 juin 2018 18h19 HE
|
Arog Pharmaceuticals, Inc.
DALLAS, June 06, 2018 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs...
Arog Pharmaceuticals Announces Oral Presentation on Crenolanib at the 2017 American Society of Hematology Annual Meeting
05 déc. 2017 07h00 HE
|
Arog Pharmaceuticals, Inc.
DALLAS, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs...
Arog Pharmaceuticals Receives FDA Fast Track Designation for Crenolanib in Relapsed or Refractory FLT3-Positive AML
01 déc. 2017 07h00 HE
|
Arog Pharmaceuticals, Inc.
DALLAS, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs...
Arog Pharmaceuticals Announces Clinical Presentations on Crenolanib at the 22nd Congress of the European Hematology Association
12 juin 2017 13h52 HE
|
Arog Pharmaceuticals, Inc.
DALLAS, June 12, 2017 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs...
Arog Pharmaceuticals Presents Crenolanib Clinical Data at the 2017 American Society of Clinical Oncology Annual Meeting
22 mai 2017 07h04 HE
|
Arog Pharmaceuticals, Inc.
DALLAS, May 22, 2017 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs...
Arog Pharmaceuticals Receives Orphan Drug Designation in the European Union for Crenolanib for the Treatment of Acute Myeloid Leukemia and Soft Tissue Sarcoma
21 nov. 2016 16h30 HE
|
Arog Pharmaceuticals, Inc.
DALLAS, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs...
Arog Pharmaceuticals Receives FDA Fast Track Designation for Crenolanib for Advanced Gastrointestinal Stromal Tumors with a D842V Mutation in the PDGFRA Gene
16 nov. 2016 16h30 HE
|
Arog Pharmaceuticals, Inc.
DALLAS, Nov. 16, 2016 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs...
AROG Pharmaceuticals to Present Clinical Data on Crenolanib at the 2016 American Society of Hematology Annual Meeting
07 nov. 2016 16h30 HE
|
Arog Pharmaceuticals, Inc.
DALLAS, Nov. 07, 2016 (GLOBE NEWSWIRE) -- AROG Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs...
Arog Pharmaceuticals Presents Crenolanib Clinical Data at the 2016 American Society of Clinical Oncology Annual Meeting
24 mai 2016 07h00 HE
|
Arog Pharmaceuticals, Inc.
DALLAS, May 24, 2016 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs...
Arog Pharmaceuticals Presents Crenolanib Clinical Data at 57th American Society of Hematology Annual Meeting
09 déc. 2015 08h00 HE
|
Arog Pharmaceuticals, Inc.
DALLAS, Dec. 9, 2015 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to...